$ANIK News

Anika (ANIK) Q2 2026 Earnings Call Transcript

Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable

Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months

Clarevia Ventures Welcomes Cheryl R. Blanchard, Ph.D., as Executive in Residence

B. Riley Securities Maintains Buy on Anika Therapeutics, Raises Price Target to $21

Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: Record Revenue and Margin ...

Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript

Anika Therapeutics Q2 Earnings Call Highlights

Anika Therapeutics (NASDAQ:ANIK) Soars on Q2 Earnings Beat, Revenue and EPS Top Estimates

Anika Reports Second Quarter 2026 Financial Results

Anika Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

President of Anika Therapeutics Picks Up 51% More Stock

Bullish On Anika Therapeutics's Pullback As Integrity Scales

Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary

Anika Therapeutics Q1 Earnings Call Highlights

Anika Therapeutics Inc (NASDAQ:ANIK) Soars on Q1 Earnings and Revenue Beat